30.05.2018 22:01:00

Sangamo Therapeutics Announces Presentation At The 2018 Jefferies Global Healthcare Conference

RICHMOND, Calif., May 30, 2018 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced today that management will present a corporate overview at the 2018 Jefferies Global Healthcare Conference in New York City. The presentation is scheduled for Wednesday, June 6th at 4:30 p.m. ET.

Sangamo Therapeutics, Inc. (PRNewsfoto/Sangamo Therapeutics, Inc.)

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will be archived on the Sangamo website following the event.

About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit www.sangamo.com.

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-presentation-at-the-2018-jefferies-global-healthcare-conference-300656791.html

SOURCE Sangamo Therapeutics, Inc.

Analysen zu Sangamo Therapeutics Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Sangamo Therapeutics Inc 2,72 7,36% Sangamo Therapeutics Inc